概括
经过工程改造的 CAR T 细胞装有介质蛋白-12 (IL12) 的装甲,显示出对固体瘤的增强疗效. 这种方法重塑了免疫抑制瘤微环境,以获得持续的抗癌效应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 在癌症治疗中,CAR T细胞疗法显示出有前途.
- 与瘤相关的巨细胞 (TAMs) 通常会产生一种免疫抑制的瘤微环境.
- 向TAM是一种增强抗癌免疫力的策略.
研究的目的:
- 为了评估改造以表达IL12的CAR T细胞的疗效.
- 评估IL12表达CAR-T细胞对固体瘤的影响.
- 为了研究这些工程细胞对瘤微环境的重塑.
主要方法:
- 工程CAR T细胞表达细胞因子IL12.
- 在实体瘤的临床前模型中利用这些装甲CAR T细胞.
- 分析瘤根除和瘤微环境的变化.
主要成果:
- 装有IL12的CAR T细胞在根除固体瘤方面表现出更高的有效性.
- 观察到持续的免疫抑制瘤微环境的重塑.
- 增强的抗瘤免疫反应与IL12表达有关.
结论:
- 用IL12对CAR T细胞进行装甲是一种可行的策略,可以改善固体瘤的治疗.
- 这种方法有效地克服了瘤诱导的免疫抑制.
- 表达IL12的CAR-T细胞在瘤学中提供了一个有前途的治疗途径.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
Cell-mediated Immune Responses
84.7K
Overview
84.7K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Antigen Presenting Cells
3.7K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.7K
Cells of the Adaptive Immune Response
9.4K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.4K


